Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Dec 22:22:100306.
doi: 10.1016/j.ensci.2020.100306. eCollection 2021 Mar.

Posterior reversible encephalopathy syndrome and COVID-19: A series of 6 cases from Lombardy, Italy

Affiliations

Posterior reversible encephalopathy syndrome and COVID-19: A series of 6 cases from Lombardy, Italy

Antonio Colombo et al. eNeurologicalSci. .

Abstract

Posterior reversible encephalopathy cases are increasingly being reported in patients affected by COVID-19, but the largest series so far only includes 4 patients. We present a series of 6 patients diagnosed with PRES during COVID-19 hospitalized in 5 Centers in Lombardia, Italy. 5 out of the 6 patients required intensive care assistence and seizures developed at weaning from assisted ventilation. 3 out of 6 patients underwent cerebrospinal fluid analysis which was normal in all cases, with negative PCR for Sars-CoV-2 genome search. PRES occurrence may be less rare than supposed in COVID-19 patients and a high suspicion index is warranted for prompt diagnosis and treatment.

Keywords: COVID-19; PRES; Seizures.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
FLAIR sequences of brain MRI.

References

    1. Hinchey J., Chavez C., Appignani B., Breen J. A reversible posterior Leuckoencephalopathy syndrome. N Engl J Med. 1996;334:494–500. - PubMed
    1. Parauda S.C., Gao V., Gewirtz A.N., Parikh N.S., Merkler A.E., Lantos J., White A., Leifer D., Navi B.B., Segal A.Z. Posterior reversible encephalopathy syndrome in patients with COVID-19. J Neurol Sci. 2020;416:117019. - PMC - PubMed
    1. Conte G., Avignone S., Carbonara M., Meneri M., Ortolano F., Cinnante C., Triulzi F. COVID-19-Associated PRES-like Encephalopathy with Perivascular Gadolinium Enhancement. AJNR Am. J. Neuroradiol. 2020 Aug 13 doi: 10.3174/ajnr.A6762. (Online ahead of print) - DOI - PMC - PubMed
    1. Princiotta Cariddi L., Tabaee Damavandi P., Carimati F., Banfi P., Clemenzi A., Marelli M., Giorgianni A., Vinacci G., Mauri M., Versino M. Reversible encephalopathy syndrome (PRES) in a COVID-19 patient. J Neurol. 2020 Nov;267(11):3157–3160. - PMC - PubMed
    1. Gatla N., Annapureddy N., Sequeira M., Jully M. Posterior reversibile encephalopathy syndrome in systemic lupus erythematosus. J Clin Rheumatol. 2013;19(6):334–340. - PubMed